Related Experiment Video

Updated: May 9, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

Runx2 induces bone osteolysis by transcriptional suppression of TSSC1

Da-Chuan Wang1, Hai-Feng Wang, Ze-Nong Yuan

  • 1Department of Orthopedics Surgery, The Provincial Hospital Affiliated to Shandong University, Shandong, China.

Biochemical and Biophysical Research Communications
|August 13, 2013
PubMed

Insights

Runx2 drives bone metastasis in breast cancer by suppressing TSSC1, a protein that inhibits cancer cell invasion. Targeting this pathway may prevent skeletal complications.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bone Metastasis Research

Background:

  • Advanced breast cancers often metastasize to bone, causing osteolytic lesions.
  • The mechanisms driving breast cancer bone metastasis are not fully understood.
  • Runx2, a key bone-specific transcription factor, is overexpressed in metastatic breast cancer cells.

Purpose of the Study:

  • To investigate the role of TSSC1 in breast cancer invasion and bone metastasis.
  • To elucidate the regulatory relationship between Runx2 and TSSC1.
  • To explore the potential of targeting the Runx2-TSSC1 axis for therapeutic strategies.

Main Methods:

  • Assessing breast cancer cell invasion.
  • Analyzing TSSC1 expression and its regulation by Runx2.
  • Evaluating the impact of Runx2 overexpression on bone osteolysis in vivo.
  • Investigating the TSSC1-dependent mechanism of Runx2-induced osteolysis.

Main Results:

  • TSSC1 was found to inhibit breast cancer cell invasion.
  • TSSC1 is a direct target of Runx2 and is negatively regulated by it.
  • Overexpression of Runx2 led to bone osteolysis, which was dependent on TSSC1 levels.
  • Runx2 promotes breast cancer metastasis to bone via TSSC1 suppression.

Conclusions:

  • Runx2 plays a critical role in promoting breast cancer bone metastasis by downregulating TSSC1.
  • TSSC1 acts as a tumor suppressor in breast cancer invasion and metastasis.
  • The Runx2-TSSC1 pathway represents a potential therapeutic target for preventing skeletal-related events in breast cancer patients.
Keywords:
Breast cancerOsteolytic lesionsRunx2TSSC1

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying DNA...